We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Micronics Advances Point-of-Care Molecular Diagnostic Applications

By LabMedica International staff writers
Posted on 10 Jun 2009
Micronics Inc. More...
(Redmond, WA, USA), a developer of point-of-care molecular and immunohematology diagnostic products, has entered into a license agreement with The Public Health Research Institute (PHRI) Properties, Inc., a nonprofit corporation wholly owned by the University of Medicine & Dentistry New Jersey (UMDNJ; Newark, NJ, USA) for the rights to Micronics' products that incorporate PHRI's molecular beacons technology.

Micronics' microfluidics technologies enable substantial reductions in the volume of a sample taken from a patient. The technologies also reduce the amount of reagents required to perform a nucleic acid amplification assay for the detection of the unique genes present in infectious disease pathogens.

Molecular beacons are specific probes developed at PHRI that fluoresce in a characteristic color if a target gene is present in a patient's sample. These probes are incorporated into Micronics' microfluidics cartridges for ease of use and prolonged storage at room temperature.

The cartridges can perform either single or multiplex pathogen detection. Each cartridge is processed by a lightweight, low-cost, battery-powered instrument with enabled software connectivity. Micronics' tests are designed to provide a result in less than thirty minutes, directly from sample acquisition in a sealed disposable cartridge.

Related Links:
Micronics Inc.
Public Health Research Institute
University of Medicine & Dentistry New Jersey



New
Gold Member
Latex Test
SLE-Latex Test
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining System
RAL DIFF-QUIK
New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: CellLENS enables the potential precision therapy strategies against specific immune cell populations in the tissue environment (Photo courtesy of MIT)

New AI System Uncovers Hidden Cell Subtypes to Advance Cancer Immunotherapy

To produce effective targeted therapies for cancer, scientists need to isolate the genetic and phenotypic characteristics of cancer cells, both within and across different tumors. These differences significantly... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.